Position in CYTK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$111,245,191
+$23,004,686 QoQ
Shares Held
1,305,848
-2.5% QoQ
Ownership
0.939%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#25
of 477 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital International Investors holds $7,948,137,729 across 16 Biotechnology names. CYTK ranks #10 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,695,144 | $2,332,218,879 | |
| 2 | RPRX |
Royalty Pharma plc
|
35,273,770 | $1,977,800,283 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
4,210,221 | $1,199,786,678 | |
| 4 | INSM |
INSMED Inc
|
8,238,124 | $878,348,780 | |
| 5 | ASND |
Ascendis Pharma A/S
|
1,988,614 | $530,403,126 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
2,361,639 | $142,548,530 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
2,963,410 | $139,398,806 | |
| 8 | COAG |
Hemab Therapeutics Holdings, Inc.
|
3,603,876 | $132,370,365 |
All Filings in CYTK
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $111,245,191 | 1,305,848 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $88,240,505 | 1,338,803 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $74,899,681 | 1,178,780 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $64,785,748 | 1,178,780 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $38,594,354 | 1,168,110 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $46,946,340 | 1,168,110 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $51,563,554 | 1,096,164 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||